← Leaderboards
Peter K Todd
University Of Michigan At Ann Arbor
$13,268,977
Attributed
$14,048,353
Total exposure
13
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.1M · FY2010–25$5M$3.8M$2.5M$1.3M$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$24,663,855 · 11
VA$0 · 4
By mechanism
P50$13,869,059 · 6
R01$8,323,386 · 2
U01$1,169,064 · 1
K08$877,464 · 1
R21$424,882 · 1
I21$0 · 1
Top collaborators
- David Loren Nelson6 shared
- Deborah A Hall1 shared
- David R Hessl1 shared
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Caitlin Marie Rodriguez$270,552
- Sid Gilman$1,651,756
- Mark R Opp$9,091,391
- Alexander Edward Linsalata$72,757
Others in their field
Top investigators on “Neurons”
- Hongkui Zeng · Allen Institute$106,358,289
- Eric Martin McDade · Washington University$94,632,845
- Ed Lein · Allen Institute$90,858,363
- Randall J Bateman · Washington University$65,841,935
- John Morris · Washington University$65,018,684
- Paul S. Aisen · Cognition Therapeutics, Inc.$58,570,460
Research focus
NeuronsProteinsTranslationsPathogenesisTherapeutic TargetToxic EffectCgg RepeatNerve DegenerationBiological ModelsFxtasMediatingSeriesGeneticPhenotypeTherapeutic DevelopmentNucleotidesFmr1Neurodegenerative DisordersTranslatingImpairmentPathway InteractionsMessenger RnaPreventInitiator Codon
Grant awards (51)
Fragile X Premutations, Mechanisms and Modifiers$1,615,502
P50 · FY2025 · HD · contact PI
Clinical Outcome Assessment and Treatment Monitoring Markers for Clinical Trial Readiness in FXTAS$1,169,064
U01 · FY2025 · NS
Hexanucleotide repeat translation in ALS and Frontotemporal Dementia$640,460
R01 · FY2025 · NS · contact PI
Project 1- CGG repeats as pathogenic driver and therapeutic target$569,765
P50 · FY2025 · HD · contact PI
Administrative Core$106,659
P50 · FY2025 · HD · contact PI
Fragile X Premutations, Mechanisms and Modifiers$1,800,000
P50 · FY2024 · HD
Hexanucleotide repeat translation in ALS and Frontotemporal Dementia$670,796
R01 · FY2024 · NS · contact PI
The FMR1 CGG repeat as functional element and therapeutic target in Fragile X associated disorders$500,047
P50 · FY2024 · HD · contact PI
CGG repeat associated translation in Fragile X-associated Tremor/Ataxia Syndrome$450,176
R01 · FY2024 · NS · contact PI
Fragile X Premutations, Mechanisms and Modifiers$1,800,000
P50 · FY2023 · HD
Hexanucleotide repeat translation in ALS and Frontotemporal Dementia$665,420
R01 · FY2023 · NS · contact PI
The FMR1 CGG repeat as functional element and therapeutic target in Fragile X associated disorders$508,267
P50 · FY2023 · HD · contact PI
CGG repeat associated translation in Fragile X-associated Tremor/Ataxia Syndrome$473,186
R01 · FY2023 · NS · contact PI
Bypassing cellular stress pathways in frontotemporal dementia and ALS$0
I01 · FY2023 · VA · contact PI
Fragile X Premutations, Mechanisms and Modifiers$1,800,000
P50 · FY2022 · HD
The FMR1 CGG repeat as functional element and therapeutic target in Fragile X associated disorders$514,882
P50 · FY2022 · HD · contact PI
CGG repeat associated translation in Fragile X-associated Tremor/Ataxia Syndrome$473,186
R01 · FY2022 · NS · contact PI
Repeat associated neurodegeneration in CANVAS$424,882
R21 · FY2022 · NS · contact PI
Bypassing cellular stress pathways in frontotemporal dementia and ALS$0
I01 · FY2022 · VA · contact PI
Fragile X Premutations, Mechanisms and Modifiers$1,800,000
P50 · FY2021 · HD
The FMR1 CGG repeat as functional element and therapeutic target in Fragile X associated disorders$521,760
P50 · FY2021 · HD · contact PI
CGG repeat associated translation in Fragile X-associated Tremor/Ataxia Syndrome$473,186
R01 · FY2021 · NS · contact PI
Bypassing cellular stress pathways in frontotemporal dementia and ALS$0
I01 · FY2021 · VA · contact PI
Fragile X Premutations, Mechanisms and Modifiers$1,800,000
P50 · FY2020 · HD
The FMR1 CGG repeat as functional element and therapeutic target in Fragile X associated disorders$532,177
P50 · FY2020 · HD · contact PI
CGG repeat associated translation in Fragile X-associated Tremor/Ataxia Syndrome$473,186
R01 · FY2020 · NS · contact PI
Hexanucleotide repeat translation in ALS and Frontotemporal Dementia$454,462
R01 · FY2020 · NS · contact PI
Bypassing cellular stress pathways in frontotemporal dementia and ALS$0
I01 · FY2020 · VA · contact PI
Hexanucleotide repeat translation in ALS and Frontotemporal Dementia$465,247
R01 · FY2019 · NS · contact PI
Hexanucleotide repeat translation in ALS and Frontotemporal Dementia$476,191
R01 · FY2018 · NS · contact PI
CGG repeat associated translation in Fragile X-associated Tremor/Ataxia Syndrome$339,063
R01 · FY2018 · NS · contact PI
RAN translation in C9orf72 repeat associated ALS and FTD$0
I01 · FY2018 · VA · contact PI
Hexanucleotide repeat translation in ALS and Frontotemporal Dementia$474,565
R01 · FY2017 · NS · contact PI
CGG repeat associated translation in Fragile X-associated Tremor/Ataxia Syndrome$339,063
R01 · FY2017 · NS · contact PI
RAN translation in C9orf72 repeat associated ALS and FTD$0
I01 · FY2017 · VA · contact PI
Hexanucleotide repeat translation in ALS and Frontotemporal Dementia$405,101
R01 · FY2016 · NS · contact PI
CGG repeat associated translation in Fragile X-associated Tremor/Ataxia Syndrome$339,063
R01 · FY2016 · NS · contact PI
Neuronal Dysfunction in Fragile X Tremor Ataxia Syndrome$0
I01 · FY2016 · VA · contact PI
CGG repeat associated translation in Fragile X-associated Tremor/Ataxia Syndrome$339,609
R01 · FY2015 · NS · contact PI
RNA Dominant Mechanisms in ALS$0
I21 · FY2015 · VA · contact PI
Neuronal Dysfunction in Fragile X Tremor Ataxia Syndrome$0
I01 · FY2015 · VA · contact PI
CGG repeat associated translation in Fragile X-associated Tremor/Ataxia Syndrome$323,159
R01 · FY2014 · NS · contact PI
Pathogenic Mechanisms in Fragile X Tremor Ataxia Syndrome$178,722
K08 · FY2014 · NS · contact PI
CGG repeat associated translation in Fragile X-associated Tremor/Ataxia Syndrome-Diversity Supplement$48,267
R01 · FY2014 · NS · contact PI
RNA Dominant Mechanisms in ALS$0
I21 · FY2014 · VA · contact PI
Neuronal Dysfunction in Fragile X Tremor Ataxia Syndrome$0
I01 · FY2014 · VA · contact PI
Pathogenic Mechanisms in Fragile X Tremor Ataxia Syndrome$178,722
K08 · FY2013 · NS · contact PI
Neuronal Dysfunction in Fragile X Tremor Ataxia Syndrome$0
I01 · FY2013 · VA · contact PI
Pathogenic Mechanisms in Fragile X Tremor Ataxia Syndrome$173,340
K08 · FY2012 · NS · contact PI
Pathogenic Mechanisms in Fragile X Tremor Ataxia Syndrome$173,340
K08 · FY2011 · NS · contact PI
Pathogenic Mechanisms in Fragile X Tremor Ataxia Syndrome$173,340
K08 · FY2010 · NS · contact PI